SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (300)10/25/2001 10:35:40 AM
From: richardred  Read Replies (1) of 724
 
Richard-I agree. With the current shares outstanding. The current market capitalization is very reasonable in comparison to peers. However, once revenue is back on the growth track it should have a big impact on the bottom line, and start attracting more attention. The bigger investors are probably waiting for that to happen, before taking more risk in a much smaller company. In this coming year, conditions are more favorable for that to happen.

Richard are you familiar with DGEN's Jeanne Yew new VP, of Business Devt? I know insiders have been sellers recently, but that hasn't kept me from buying on dips below 6.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News